We are proud to announce that Moehs has taken one step further on the nitrosamines project by publishing an article in the scientific Journal of Separation Science.
We announce the appointment of Mr. Javier del Rio as its new CEO replacing Mr. Francisco Escribano after a long career within Moehs. Mr. del
At Moehs we encourage and promote the talent of new students! During these months, we received the visit of 110 students of FP Dual who
Operative and fully qualified since 2019, the Kilo Lab was successfully inspected by the Spanish Health Agency that granted us the GMP certificate of this
Moehs Group has recently incorporated to its capabilities a GMP compliant Kilo Lab Unit for the development and commercial production of High Potent APIs (HPAPIs).
Moehs, as the leader in the API production sector in Spain
The Moehs Group launches a new web space to continue attracting talent.
APIC Guidance on Nitrosamines Risk Assessment
Moehs Group obtains the Certificate of suitability of Monographs of the (CEP), granted by the (EDQM), as a manufacturer of DULOXETINA HCL.
Adamas Pharmaceuticals says ?on Oct 4, unit entered into amended and restated API supply agreement with Moehs Ibérica - SEC Filing